Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $41.7400 (8.19%) ($39.4200 - $41.8700) on Mon. Feb. 25, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.58% (three month average) | RSI | 65 | Latest Price | $41.7400(8.19%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 0.7% a day on average for past five trading days. | Weekly Trend | ATRA advances 1.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) ARKG(50%) IBB(50%) IWO(48%) ARKK(47%) | Factors Impacting ATRA price | ATRA will decline at least -2.29% in a week (0% probabilities). VXX(-13%) UUP(-13%) TLT(-13%) VIXM(-11%) UNG(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.29% (StdDev 4.58%) | Hourly BBV | 0 () | Intraday Trend | 5.9% | | | |
|
5 Day Moving Average | $39.63(5.32%) | 10 Day Moving Average | $39.54(5.56%) | 20 Day Moving Average | $38.48(8.47%) | To recent high | -2.9% | To recent low | 47% | Market Cap | $3.102b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |